Literature DB >> 10203854

The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience.

K J O'Donovan1, W G Tourtellotte, J Millbrandt, J M Baraban.   

Abstract

The EGR family of transcription regulatory factors, which is implicated in orchestrating the changes in gene expression that underlie neuronal plasticity, has attracted the attention of both molecular and systems neuroscientists. In this article, the advances made in both these fields of research are reviewed. Recent systems-based studies underscore the remarkable sensitivity and specificity of the induction of the expression of genes encoding EGR-family members in naturally occurring plasticity paradigms. However, they also challenge conventional views of the role of this family in plasticity. Recent molecular studies have identified the gonadotropin subunit, luteinizing hormone beta, as an EGR1-regulated gene in vivo and uncovered an essential role for EGR3 in muscle-spindle development. In addition, the discovery of novel proteins that are capable of suppressing EGR-mediated transcription cast doubt over the prevalent assumption that changes in EGR mRNA or protein levels provide an accurate measure of EGR-driven transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203854     DOI: 10.1016/s0166-2236(98)01343-5

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  163 in total

1.  Blockade of NGF-induced neurite outgrowth by a dominant-negative inhibitor of the egr family of transcription regulatory factors.

Authors:  Y Levkovitz; K J O'Donovan; J M Baraban
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation.

Authors:  Y Levkovitz; J M Baraban
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 3.  DeltaFosB: a sustained molecular switch for addiction.

Authors:  E J Nestler; M Barrot; D W Self
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex.

Authors:  Yechiel Levkovitz; Jay M Baraban
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

5.  EGR4 displays both a cell- and intracellular-specific localization pattern in the developing murine testis.

Authors:  Cathryn A Hogarth; Debra Mitchell; Christopher Small; Michael Griswold
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

6.  The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.

Authors:  Feng Fang; Kohtaro Ooka; Swati Bhattacharyya; Swati Bhattachyya; Jun Wei; Minghua Wu; Pan Du; Simon Lin; Francesco Del Galdo; Carol A Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

7.  Regulation of cpg15 by signaling pathways that mediate synaptic plasticity.

Authors:  Tadahiro Fujino; Wei-Chung Allen Lee; Elly Nedivi
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

8.  Current aspects of hearing loss from occupational and leisure noise.

Authors:  S Plontke; H-P Zenner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

9.  GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation.

Authors:  Ning Shen; Yue Shao; Shan-Shan Lai; Long Qiao; Run-Lin Yang; Bin Xue; Fei-Yan Pan; Hua-Qun Chen; Chao-Jun Li
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

10.  Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.

Authors:  Julie Salzmann; Cynthia Marie-Claire; Stephanie Le Guen; Bernard P Roques; Florence Noble
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.